In July 2010, new performance measures were established for epilepsy (child and adult) and major depressive disorder (MDD) (child and adolescent). These measures can be reported by pediatricians and pediatric subspecialists in addition to the several other measures that are pediatric specific (eg, acute otitis externa/otitis media with effusion, pediatric acute gastroenteritis) or applicable to children and adults (eg, asthma).
Using Category II Current Procedural Terminology (CPT®) codes allows a practice to monitor performance, patient compliance, and outcomes for many conditions and diseases. Although reporting Category II codes is not mandatory, Medicare providers may report certain quality measurements under the Physician Quality Reporting Initiative (PQRI) and receive incentive payments. Commercial payers are also moving toward incentive payment systems.
Measures will be reported by the physician providing care to children and adults with a diagnosis of epilepsy.
Next month's AAP Pediatric Coding Newsletter™ will address the new Category II...